High prevalence of thyroid dysfunction and autoimmune thyroiditis in adolescents after elimination of iodine deficiency in the Eastern Black Sea Region of Turkey

Thyroid

Volumn 16, Issue 12, 2006, Pages 1265-1271

  Bastemir, Mehmet ^a,b   Emral, Rifat ^a   Erdogan, Gurbuz ^a   Gullu, Sevim ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; GOITER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THYROID DISEASE; TURKEY (REPUBLIC); URINARY EXCRETION;

ADOLESCENT; DEFICIENCY DISEASES; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE; MALE; PREVALENCE; THYROID DISEASES; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; TURKEY;

EID: 33846140810     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.1265     Document Type: Article

References (57)

1. WHO/UNICEF/ICCIDD 2001 Assessment of the Iodine Deficiency Disorders and Monitoring Their Elimination. WHO, Geneva.
2. Koutras DA 1996 Control of efficiency and results, and adverse effects of excess iodine administration on thyroid function. Ann Endocrinol (Paris) 57:463-469.
3. Todd CH, Allain T, Gomo ZA, Hasler JA, Ndiweni M, Oken E 1995 Increase in thyrotoxicosis associated with iodine supplements in Zimbabwe. Lancet 346:1563-1564.
4. Bourdoux PP, Ermans AM, Mukalay WA, Mukalay A, Filetti S, Vignery R 1996 Iodine induced thyrotoxicosis in Kivu, Zaire. Lancet 347:552-553.
5. Mostbeck A, Galvan G, Bauer P, Eber O, Atefie K, Dam K, Feichtinger H, Fritzsche H, Haydl H, Kohn H, Konig B, Koriska K, Kroiss A, Lind P, Markt B, Maschek W, Pesl H, Ramschak-Schwarzer S, Riccabona G, Stockhammer M, Zechmann W 1998 The incidence of hyperthyroidism in Austria from 1987-1995 before and after and increase in salt iodization in 1990. Eur J Nucl Med 25:367-374.
6. Connolly RJ, Vidor GI, Stuart JC 1970 Increase in thyrotoxicosis in endemic goiter area after iodination of bread. Lancet 1:500-502.
7. Vidor GI, Stewart JC, Wall JR, Wangel A, Hetzel BS 1973 Pathogenesis of iodine-induced thyrotoxicosis: studies in Northern Tasmania. J Clin Endocrinol Metab 37:901-909.
8. Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG 2001 Iodine-induced hypothyroidism. Thyroid 11:501-510.
9. Ruwhof C, Drexhage HA 2001 Iodine and thyroid autoimmune disease in animal models. Thyroid 11:427-436.
10. Harach HR, Escalante DA, Onativia A, Outes JL, Day ES, Williams ED 1985 Thyroid carcinoma and thyroiditis in endemic goiter region before and after iodine prophylaxis. Acta Endocrinol (Copenh) 108:55-60.
11. Boukis MA, Koutras DA, Souvatzoglu A, Evangelopoulou A, Vrontakis M, Moulopoulos SD 1983 Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab 57:859-862.
12. Costa A, de Filippis V, Balsamo A, Ravarino N, Testori O, Torchio B, Valmaggia P, Zoppetti G 1984 Serum auto-antibodies and thyroid lymphocytic infiltration in endemic goiter. Clin Exp Immunol 56:143-148.
13. Costa A, Benedetto V, Ricci C, Borelli P, Fadda E, Ravarino N, Torchio B, Dario U, Fragapane P, Varvello G, De Filippis V 1986 Immunological features of endemic goiter. Clin Immunol Immunopathol 41:265-272.
14. Doufas AG, Mastorakos G, Chatziioannou S, Tseleni-Balafouta S, Piperingos G, Boukis MA, Mantzos E, Caraiskos CS, Mantzos J, Alevizaki M, Koutras DA 1999 The predominant form of non-toxic goiter in Greece is now autoimmune thyroiditis. Eur J Endocrinol 140:505-511.
15. Erdoǧan G, Erdoǧan MF, Emral R, Baştemir M, Sav H, Haznedaroǧlu D, Ustundag M, Kose R, Kamel N, Gene Y 2002 Iodine status and goiter prevalence of Turkey before mandatory iodization. J Endocrinol Invest 25:224-228.
16. Erdoǧan G, Erdoǧan MF, Delange F, Sav H, Gullu S, Kamel N 2000 Moderate to severe iodine deficiency in three endemic goiter areas from the Black Sea region and the capital of Turkey. Eur J Epidemiol 16:1131-1134.
17. Brunn J, Blocjk U, Ruf J, Kunze WP, Scriba PC 1981 Volumetrie der schilddrusenlappen mittels real-time-sonographie. Deutsch Med Wochenschr 287:1206-1207.
18. Takalo RM, Makarainen HP, Jaakkola RK 1991 Thyroid gland volume and echo structure in 13-year-old children in northen Finland. Acta Endocrinol (Copenh) 124:238-244.
19. WHO/ICCIDD 1997 Recommended normative values for thyroid volume in children aged 6-15 years. Bull World Health Organ 75:95-97.
20. Emral R, Bastemir M, Gullu S, Erdogan G 2003 Thyroid consequences of the Chernobyl nuclear power station accident on the Turkish population. Eur J Endocrinol 148:497-503.
21. Pacini F, Vorontsova T, Molinaro E, Kuchinskaya E, Agate L, Shavrova E, Astachova L, Chiovato L, Pinchera A 1998 Prevalence of thyroid autoantibodies in children and adolescents from Belarus exposed to the Chernobyl radioactive fallout. Lancet 352:763-766.
22. Szybinski Z, Nauman J, Gembicki M, Rybakowa M, Huszno B, Golkowski F, Drozdz R, Stanuch H, Starkel L, Skalski M 1993 Principles, main goals and methods of the nationwide program: investigations on iodine deficiency and model of iodine prophylaxis in Poland. Endokrynol Pol Polska 44:235-248.
23. Dayan CM, Daniels GH 1996 Chronic autoimmune thyroiditis. N Engl J Med 335:99-107.
24. Oechslin E, Hedinger C 1985 Hashimoto's lymphomatous thyroiditis and endemic Struma. Schweiz Med Wochenschr 115:1182-1191.
25. Hintze G, Emrich D, Kobberling J 1989 Treatment of endemic goiter due to iodine deficiency with iodine, levothyroxine or both: results of a multicenter trial. Eur J Clin Invest 19:527-534.
26. Kusic Z, Lechpammer S, Lukinac L, Petrovic I, Nothig-Hus D 1999 First beneficial results of the implementation of Croatian new law on salt iodination. J Endocrinol Invest 22:747-751.
27. Lindberg O, Andersson LC, Lamberg BA 1989 The impact of 25 years of iodine prophylaxis on the adult thyroid weight in Finland. J Endocrinol Invest 12:789-793.
28. World Health Organization, United Nations International Children's Education Fund and International Council for Control of Iodine Deficiency Disorders. 1994 Indicators for Assessing IDD and Their Control Through Salt Iodination. WHO/NUT, Geneva, pp 6-11.
29. Kasagi K, Takeuchi R, Misaki T, Kousaka T, Miyamoto S, Iida Y, Konishi J 1997 Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects. J Endocrinol Invest 20:183-188.
30. Rose NR, Rasooly L, Saboori AM, Burek L 1999 Linking iodine with autoimmune thyroiditis. Environ Health Perspect 107:749-752.
31. Sundick RS, Bagchi N, Brown TR 1992 The role of iodine in thyroid autoimmunity: from chickens to humans-a review. Autoimmunity 13:61-68.
32. Rose NR, Saboori AM, Rasooly L, Bureck CL 1997 The role of iodine in autoimmune thyroiditis. CRC Crit Rev Immunol 17:511-517.
33. Rasooly L, Bureck CL, Rose NR 1996 Iodine induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol 81:287-292.
34. Gardas A 1991 The influence of iodine on the immunological properties of thyroglobulin and its immunological complexes. Autoimmunity 9:331-336.
35. Papanastasiou L, Alevizaki M, Piperingos G, Mantzos E, Tseleni-Balafouta S, Koutras DA 2000 The effect of iodine administration on the development of thyroid autoimmunity in patients with nontoxic goiter. Thyroid 10:493-497.
36. Boyages SC, Bloot AM, Maberly GF, Eastman CJ, Li M, Qian QD, Liu DR, van der Gaag RD, Drexhage HA 1989 Thyroid autoimmunity in the endemic goiter caused by excessive iodine intake. Clin Endocrinol 31:453-465.
37. Takamatsu J, Yoshida S, Yokozawa T, Hirai K, Kuma K, Ohsawa N, Hosoya T 1998 Correlation of antithyroglobulin and antithyroid-peroxidase antibody profiles with clinical and ultrasound characteristics of chronic thyroiditis. Thyroid 12:1101-1106.
38. Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G 2001 Long-term outcome of interferon-alpha- induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. J Clin Endocrinol Metab 86:1925-1929.
39. Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikoscch P, Gomez I 1999 Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 8:1179-1183.
40. Stanbury JB, Ermans AE, Bourdoux P, Todd C, Oken E, Tonglet R, Vidor G, Braverman LE, Medeiros-Neto G 1998 Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 8:83-100.
41. Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A 1999 The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84:561-566.
42. Lind P, Kumnig G, Heinisch M, Igerc I, Mikosch P, Gallowitsch HJ, Kresnik E, Gomez I, Unterweger O, Aigner H 2002 Iodine supplementation in Austria: methods and results. Thyroid 12:903-907.
43. Corvilain B, Van Sande J, Dumont JE, Bourdoux P, Ermans AM 1998 Autonomy in endemic goiter. Thyroid 8:107-113.
44. Marqusee E, Haden ST, Utiger RD 1998 Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am 27:37-49.
45. Berghout A, Wiersinga WM, Smits NJ, Touber JL 1990 Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 89:602-608.
46. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J, Vassart G 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 7:396-401.
47. Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R 2005 Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocrinol Rev 26:504-524.
48. Krohn K, Wohlgemuth S, Gerber H, Paschke R 2000 Hot microscopic areas of iodine-deficient euthyroid goiters contain constitutively activating TSH receptor mutations. J Pathol 192:37-42.
49. Yang F, Teng W, Shan Z, Guan H, Li Y, Jin Y, Hu F, Shi X, Tong Y, Chen W, Yuan B, Wang Z, Cui B, Yang S 2002 Epidemiological survey on the relationship between different iodine intakes and the prevalence of hyperthyroidism. Eur J Endocrinol 146:613-618.
50. Cakir M 2005 Euthyroid Graves' ophthalmopathy with negative autoantibodies. J Natl Med Assoc 97:1547-1549.
51. Mariotti S, Chiovato L, Franceschi C, Pinchera A 1998 Thyroid autoimmunity and aging. Exp Gerontol 33:535-541.
52. Henzen C, Buess M, Brander L 1999 Iodine-induced hyperthyroidism (iodine-induced Basedow's disease): a current disease picture. Schweiz Med Wochenschr 129:658-664.
53. Roti E, Uberti ED 2001 Iodine excess and hyperthyroidism. Thyroid 11:493-500.
54. Rath T, Meissl G 1988 Induction of hyperthyroidism in burn patients treated topically with povidone-iodine. Burns Incl Therm Inj 14:320-322.
55. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H 2000 Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol 143:485-491.
56. Schuppert F, Ehrenthal D, Frilling A, Koichi S, Napolitano G, Kohn LD 2000 Increased major histocompatibility complex (MHC) expression in nontoxic goiters is associated with iodide depletion, enhanced ability of the follicular thyroglobulin to increase MHC gene expression, and thyroid autoantibodies. J Clin Endocrinol Metab 85:858-867.
57. Loviselli A, Velluzzi F, Mossa P, Cambosu MA, Seci G, Atzeni F, Taberlet A, Balestrieri A, Martino E, Grasso L, Songini M, Bottazzo GF, Mariotti S, Sardinian Schoolchildren Study Group 2001 The Sardinian Autoimmunity Study: 3. Studies on circulating antithyroid antibodies in Sardinian Schoolchildren: relationship to goiter prevalence and thyroid function. Thyroid 11:849-857.